These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 32527504)
1. Treatment for Mycobacterium abscessus complex-lung disease. Weng YW; Huang CK; Sy CL; Wu KS; Tsai HC; Lee SS J Formos Med Assoc; 2020 Jun; 119 Suppl 1():S58-S66. PubMed ID: 32527504 [TBL] [Abstract][Full Text] [Related]
2. Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of Ignatius EH; Rimal B; Panthi CM; Belz DC; Lippincott CK; Deck DH; Serio AW; Lamichhane G mSphere; 2024 Jul; 9(7):e0038124. PubMed ID: 38980071 [TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease. Choi H; Kim SY; Kim DH; Huh HJ; Ki CS; Lee NY; Lee SH; Shin S; Shin SJ; Daley CL; Koh WJ Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739795 [TBL] [Abstract][Full Text] [Related]
4. Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report. Kim SY; Shin SJ; Jeong BH; Koh WJ BMC Infect Dis; 2016 May; 16():207. PubMed ID: 27188784 [TBL] [Abstract][Full Text] [Related]
5. Rapid Detection of Clarithromycin and Amikacin Resistance in Mycobacterium abscessus Complex by High-Resolution Melting Curve Analysis. Li H; Mulati G; Shang Y; Yao C; Wang Y; Ren W; Xue Z; Li S; Pang Y Microbiol Spectr; 2022 Jun; 10(3):e0057422. PubMed ID: 35638787 [TBL] [Abstract][Full Text] [Related]
6. Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease. Jhun BW; Yang B; Moon SM; Lee H; Park HY; Jeon K; Kwon OJ; Ahn J; Moon IJ; Shin SJ; Daley CL; Koh WJ Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661870 [TBL] [Abstract][Full Text] [Related]
7. Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections. Jeong SH; Kim SY; Huh HJ; Ki CS; Lee NY; Kang CI; Chung DR; Peck KR; Shin SJ; Koh WJ Int J Infect Dis; 2017 Jul; 60():49-56. PubMed ID: 28522316 [TBL] [Abstract][Full Text] [Related]
8. Genomic Analysis of Mycobacterium abscessus Complex Isolates from Patients with Pulmonary Infection in China. Jin P; Dai J; Guo Y; Wang X; Lu J; Zhu Y; Yu F Microbiol Spectr; 2022 Aug; 10(4):e0011822. PubMed ID: 35863029 [TBL] [Abstract][Full Text] [Related]
9. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease. Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan. Lee MC; Sun PL; Wu TL; Wang LH; Yang CH; Chung WH; Kuo AJ; Liu TP; Lu JJ; Chiu CH; Lai HC; Chen NY; Yang JH; Wu TS J Antimicrob Chemother; 2017 Oct; 72(10):2782-2786. PubMed ID: 29091186 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity between linezolid and other antimicrobial agents against Mycobacterium abscessus complex. Zhang Z; Lu J; Song Y; Pang Y Diagn Microbiol Infect Dis; 2018 Jan; 90(1):31-34. PubMed ID: 29089153 [TBL] [Abstract][Full Text] [Related]